ENTERA BIO
Entera Bio is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the most straight forward and user friendly approach to medical treatment. Entera Bio has key personnel with the relevant know how, experience and networks working together to enable rapid development of its products. The company has an experienced management team with more than 50 years of combined drug development experience.
ENTERA BIO
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.enterabio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
23.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA
Similar Organizations
Dermira
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
KeChow Pharma
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Medifron DBT
Medifron DBT is a clinical stage biopharmaceutical company focusing on the development of Alzheimer's disease and neuropathic pain.
OnQuality Pharmaceuticals
OnQuality Pharmaceuticals involves in development and commercialization of innovative drugs and drug delivery systems.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Zhenge Biotech
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Current Employees Featured
Founder
Stock Details
Investors List
Pontifax
Pontifax investment in Venture Round - Entera Bio
Official Site Inspections
http://www.enterabio.com Semrush global rank: 5.14 M Semrush visits lastest month: 1.58 K
- Host name: israel237.jetserver.net
- IP address: 81.218.117.77
- Location: Tel Aviv Israel
- Latitude: 32.0678
- Longitude: 34.7647
- Timezone: Asia/Jerusalem
More informations about "Entera Bio"
ENTERA BIO - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 972-2-532-7151 Entera Bio is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract.See details»
Investor Relations - Entera Bio Ltd.
Aug 20, 2024 Entera is a leader in the development of orally delivered macromolecules, including peptides and other therapeutic proteins. The Company focuses on significant unmet โฆSee details»
Entera Bio Ltd. | LinkedIn
Entera is a clinical stage company focused on developing oral peptide or protein replacement therapies for significant unmet medical needs where an oral tablet form holds the potential to ...See details»
Investor FAQs - Entera Bio Ltd.
Entera Bio is headquarterd at: Minrav Building - Fifth Floor Kiryat Hadassah Jerusalem 9112002, IsraelSee details»
Entera Bio - Overview, News & Similar companies | ZoomInfo.com
Jun 3, 2024 Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research JERUSALEM, April 08, 2024 โฆSee details»
Entera Bio - Products, Competitors, Financials, Employees, โฆ
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates. Nov 8, 2024. Entera Bio Ltd. JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. โฆSee details»
Entera Bio Ltd. (Entera Bio Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
For more information, visit www.enterabio.com or follow us on LinkedIn, X (formerly Twitter), Facebook and Instagram. About OPKO Health OPKO Health is a multinational โฆSee details»
Entera Bio Ltd. (ENTX) Company Profile & Overview - Stock Analysis
Jun 28, 2018 Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs where an oral tablet form holds the โฆSee details»
Entera Bio - VentureRadar
Develops innovative biotechnology solutions focused on oral delivery methods for large molecules and biologic substances in healthcare. " Entera Bio is a product-focused biotechnology โฆSee details»
Entera Bio Provides Business Highlights and Financial Results for โฆ
Aug 11, 2022 Contact: Entera Bio: Ms. Miranda Toledano Chief Executive Officer Entera Bio Email: [email protected] Phone: +972-58-55-88-470 IR: Mr. Christopher M. Calabrese โฆSee details»
Entera Bio
O 3 Entera Bio: Leader in Oral Delivery of Therapeutic Proteins โข First-in-class, daily tablet form of protein and peptide replacement therapies developed for patients to live healthier and injection โฆSee details»
Entera Bio - Craft
Oct 29, 2024 Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics. The Company is conducting clinical trials on its โฆSee details»
Entera Bio Issues Letter to Shareholders - EnteraBio
BOSTON and JERUSALEM, Jan. 11, 2021 (GLOBE NEWSWIRE) โ Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today โฆSee details»
Entera Bio Announces Full Year 2023 Financial Results and โฆ
Dec 31, 2023 For more information on Entera Bio, visit www.enterabio.com or follow us on LinkedIn, Twitter, Facebook, Instagram. Cautionary Statement Regarding Forward-Looking โฆSee details»
Entera Bio Appoints Two New External Independent Members to โฆ
JERUSALEM, Oct. 02, 2018 (GLOBE NEWSWIRE) โ Entera Bio Ltd. (NASDAQ: ENTX and ENTXW) announced today the appointment of Faith L. Charles and Miranda J. Toledano to โฆSee details»
Entera Bio Ltd. - Cruelty Free Investing
Company Website: https://www.enterabio.com Contact: [email protected] ©2024 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization โฆSee details»
Press Releases | Investor Relations | Entera Bio Ltd.
JERUSALEM, March 26, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (โEnteraโ or the โCompanyโ), a leader in the development of orally delivered peptides, โฆSee details»
Entera Bio Ltd. (ENTX) Stock Price, News, Quote & History - Yahoo โฆ
Find the latest Entera Bio Ltd. (ENTX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare โฆ
JERUSALEM, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (โEnteraโ or the โCompanyโ) a leader in the development of orally delivered peptides and โฆSee details»
Release Details - Entera Bio Ltd.
JERUSALEM, March 26, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (โEnteraโ or the โCompanyโ), a leader in the development of orally delivered peptides, โฆSee details»